Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
This document reports a Phase 3 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
A Phase 3 clinical trial evaluating stem cell transplantation for hematologic malignancies has completed. The study covered several conditio…
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on stem cell transplantation as immunotherapy for hematologic malignancies. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]
A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing m…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Behavioral Intervention For BMT/SCT Survivors
A completed clinical trial evaluated a behavioral intervention for bone marrow transplant and stem cell transplant survivors. The study incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-12-15FDA Approved: MOZOBIL — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Mozobil (plerixafor) under an Original Application (NDA022311) to mobilize hematopoietic stem cells in combination with G-CSF f…
-
CLINICAL_TRIALS research · 2008-12-11Clinical Trial Update: Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating Zevalin (ibritumomab tiuxetan) in combination with non‑myeloablative allogeneic stem cell transp…
-
CLINICAL_TRIALS trial_result · 2008-10-22Clinical Trial Update: Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma [Phase 1]
Phase 1 study evaluating CHOP chemotherapy in combination with Campath (alemtuzumab) for T-cell lymphoma, NK-cell lymphoma, and other non-Ho…
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: A Study of Patients With AIDS Syndrome
This is a completed clinical trial sponsored by NIAID studying patients with AIDS-related conditions such as Kaposi sarcoma and non-Hodgkin …
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma [Phase 1]
This update notes the completion of a Phase 1 study evaluating recombinant interleukin-21 in combination with Rituxan for non-Hodgkin lympho…
-
CLINICAL_TRIALS withdrawal · 2008-09-05Clinical Trial Update: A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma [Phase 1]
This Phase I study evaluating safety and tolerability in adults with lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer [Phase 1]
Pfizer-sponsored Phase 1 trial of an intravenously administered cyclin-dependent kinase inhibitor in patients with advanced cancer was termi…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update on BAY 59-8862 for refractory Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training [Phase 2]
Phase 2 trial completion evaluating an antioxidant in cancer-cachectic patients undergoing exercise training.
-
CLINICAL_TRIALS trial_result · 2008-06-06Clinical Trial Update: Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma. [Phase 1]
Open-label Phase 1 study evaluating whether omeprazole affects the pharmacokinetics of Velcade (bortezomib) in patients with advanced solid …
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL [Phase 2]
A Phase 2 clinical trial update from St. Jude Children's Research Hospital evaluating treatment for Burkitt lymphoma/leukemia and B-cell non…
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma [Phase 2]
A Phase II trial evaluating CHOP-R followed by Zevalin and Rituxan in follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating PBPC mobilization with chemotherapy followed by pegfilgrastim or filgrastim in subjects with Non-Hodgkin lymphoma; …
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Large Cell Lymphoma Pilot Study III [NA]
This is a completed update on St. Jude's Large Cell Lymphoma Pilot Study III, a clinical trial investigating treatment for large cell/non-Ho…
-
CLINICAL_TRIALS trial_result · 2008-04-23Clinical Trial Update: Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma [NA]
Clinical trial update noting the completion of a study evaluating treatment for stage III or IV non-Hodgkin lymphoma, including lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2008-04-21Clinical Trial Update: Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial comparing outpatient immunotherapy with Rituximab plus Aldesleukin versus Rituximab alone in Non-Hodgkin's lymphoma was termin…
-
FDA approval · 2008-03-25FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)
FDA has approved a supplemental application for Zevalin (ibritumomab tiuxetan) filed by Acrotech Biopharma Inc.
-
CLINICAL_TRIALS trial_result · 2008-03-18Clinical Trial Update: Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma [Phase 2]
Phase 2 trial evaluating a personalized active immunotherapy vaccine and sargramostim after standard Rituximab and chemotherapy for initial …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [Phase 2]
This Phase II randomized trial compares EPOCH II alone to EPOCH II with immunotherapy in Hodgkin lymphoma and Non-Hodgkin lymphoma; the stud…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
This completed National Cancer Institute study evaluates chronic and late health effects in long-term survivors of Non-Hodgkin lymphoma and …